Skip to main navigation

US

How It Works
The Results
FAQ
Why Sleep Apnea
About ProSomnus
Contact Us

Healthcare Providers

Overview
News Releases

Events

Presentations
Stock Quote & Chart

Historic Price Lookup
Documents & Charters

Board of Directors

Management

Committee Composition
SEC Filings
Investor FAQs

Email Alerts

Contact Investor Relations

News Releases

Year

Sep 21, 2023

ProSomnus Raises $10 Million To Fuel Growth and Optimize Operations

Sep 14, 2023

ProSomnus Precision Obstructive Sleep Apnea Devices to be Featured in Scientific Abstracts and Podium Presentations at Upcoming Medical Conferences

Aug 23, 2023

Updated Clinical Trial Data Indicates Precision Oral Appliance Therapy with ProSomnus Devices is Non-Inferior to CPAP Therapy for the Treatment of Moderate to Severe Obstructive Sleep Apnea

Aug 03, 2023

ProSomnus Reports Record Second Quarter 2023 Top-Line Financial Results

Jul 13, 2023

ProSomnus to Design Head-to-Head Clinical Trial vs. Hypoglossal Nerve Stimulation

Jul 06, 2023

ProSomnus Announces Second Quarter 2023 Investor Call and Business Update

Jun 28, 2023

71% of Self-identified Snorers Have Never Consulted a Healthcare Professional

Jun 08, 2023

Data Presented at the 2023 SLEEP Annual Meeting Strengthens Evidence for ProSomnus Precision Oral Appliance Therapy for the Treatment of Obstructive Sleep Apnea

May 30, 2023

Data Presented at the 2023 American Academy of Dental Sleep Medicine and the American Thoracic Society Meetings Further Validate ProSomnus Precision Oral Appliance Therapy for the Treatment of Obstructive Sleep Apnea

May 09, 2023

ProSomnus Reports First Quarter 2023 Financial Results

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 22

For More
Information

Email us at Investors@ProSomnus.com

Patients

Healthcare Providers

Our Company

United States

Facebook Instagram Youtube LinkedIn

News Releases

For More Information

For More
Information